UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 7.

Versluis, J; In't Hout, F E; Devillier, R; van Putten, W L; Manz, M G; Vekemans, M C; Legdeur, M C; Passweg, J R; Maertens, J; Kuball, J; Biemond, B J; Valk, P J; van der Reijden, B A; Meloni, G; Schouten, H C; Vellenga, E; Pabst, T; Willemze, R; Löwenberg, B; Ossenkoppele, G; Baron, F; Huls, G; Cornelissen, J J (2016). Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio. Leukemia, 31(1):26-33.

Klemke, C D; Booken, N; Weiss, C; Nicolay, J P; Goerdt, S; Felcht, M; Géraud, C; Kempf, W; Assaf, C; Ortonne, N; Battistella, M; Bagot, M; Knobler, R; Quaglino, P; Arheiliger, B; Santucci, M; Jansen, P; Vermeer, M H; Willemze, R (2015). Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases. British Journal of Dermatology, 173(1):93-105.

Olsen, E A; Whittaker, S J; Kim, Y H; Duvic, M; Prince, H M; Lessin, S R; Wood, G S; Willemze, R; Demierre, M F; Pimpinelli, N; Bernengo, M G; Ortiz-Romero, P L; Bagot, M; Estrach, T; Guitart, J; Knobler, R; Sanches, J A; Iwatsuki, K; Sugaya, M; Dummer, R; Pittelkow, M; Hoppe, R; Parker, S; Geskin, L; Pinter-Brown, L; Girardi, M; Burg, G; Ranki, A; Vermeer, M H; Horwitz, S; Heald, P; Rosen, S; Cerroni, L; Dreno, B; Vonderheid, E C (2011). Clinical end points and response criteria in mycosis fungoides and sezary syndrome: a consensus statement of the international society for cutaneous lymphomas, the United States cutaneous lymphoma consortium, and the cutaneous lymphoma task force of the European organisation for research and treatment of cancer. Journal of Clinical Oncology, 29(18):2598-2607.

Kempf, W; Pfaltz, K; Vermeer, M H; Cozzio, A; Ortiz-Romero, P L; Bagot, M; Olsen, E; Kim, Y H; Dummer, R; Pimpinelli, N; Whittaker, S; Hodak, E; Cerroni, L; Berti, E; Horwitz, S; Prince, H M; Guitart, J; Estrach, T; Sanches, J A; Duvic, M; Ranki, A; Dreno, B; Ostheeren-Michaelis, S; Knobler, R; Wood, G; Willemze, R (2011). EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Blood, 118(15):218-225.

Senff, N J; Zoutman, W H; Vermeer, M H; Assaf, C; Berti, E; Cerroni, L; Espinet, B; de Misa Cabrera, R F; Geerts, M L; Kempf, W; Mitchell, T J; Paulli, M; Petrella, T; Pimpinelli, N; Santucci, M; Whittaker, S J; Willemze, R; Tensen, C P (2009). Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type. Journal of Investigative Dermatology, 129(5):1149-1155.

Willemze, R; Dreyling, M (2009). Primary cutaneous lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of Oncology, 20(Suppl.):iv115-iv118.

Kempf, W; Ostheeren-Michaelis, S; Paulli, M; Lucioni, M; Wechsler, J; Audring, H; Assaf, C; Rüdiger, T; Willemze, R; Meijer, C J L M; Berti, E; Cerroni, L; Santucci, M; Hallermann, C; Berneburg, M; Chimenti, S; Robson, A; Marschalko, M; Kazakov, D V; Petrella, T; Fraitag, S; Carlotti, A; Courville, P; Laeng, H; Knobler, R; Golling, P; Dummer, R; Burg, G (2008). Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For Research and Treatment of Cancer (EORTC). Archives of Dermatology, 144(12):1609-1617.

This list was generated on Fri Jul 21 14:46:09 2017 CEST.